The Current Ratio as of September 2024 (TTM) for NuCana plc (NCNA) is 1.08

According to NuCana plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.08. This represents a change of -39.60% compared to the average of 1.79 of the last 4 quarters.

NuCana plc (NCNA) Historical Current Ratio (quarterly & annually)

How has NCNA Current Ratio performed in the past?

The mean historical Current Ratio of NuCana plc over the last ten years is 14.22. The current 1.08 Current Ratio has changed 659.83% with respect to the historical average. Over the past ten years (40 quarters), NCNA's Current Ratio was at its highest in in the March 2018 quarter at 34.90. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

NuCana plc (NCNA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NuCana plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NuCana plc (NCNA) Average Current Ratio

How has NCNA Current Ratio performed in the past?

The current Current Ratio of NuCana plc (NCNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NuCana plc (NCNA) Current Ratio vs. Peers

How is NCNA’s Current Ratio compared to its peers?

NuCana plc’s Current Ratio is less than eFFECTOR Therapeutics, Inc. (0), greater than Virios Therapeutics, Inc. (1.03), less than Zura Bio Limited (7.27), less than Navidea Biopharmaceuticals, Inc. (12.57), greater than ZyVersa Therapeutics, Inc. (0.56), greater than Cidara Therapeutics, Inc. (0.06), less than Silence Therapeutics plc (4.25), less than Applied Therapeutics, Inc. (9.83), less than CytomX Therapeutics, Inc. (2.30), greater than Rani Therapeutics Holdings, Inc. (1.00), less than Vincerx Pharma, Inc. (0), less than Tenaya Therapeutics, Inc. (1.93), less than Corvus Pharmaceuticals, Inc. (3.43), less than ALX Oncology Holdings Inc. (6.28), less than Mereo BioPharma Group plc (3.62), less than Acumen Pharmaceuticals, Inc. (4.39), less than Day One Biopharmaceuticals, Inc. (6.07), less than Inozyme Pharma, Inc. (17.37), less than Galera Therapeutics, Inc. (4.09), less than null (9.84), less than null (5.63),

Build a custom stock screener for NuCana plc (NCNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NuCana plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NuCana plc (NCNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NuCana plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.